Fabrizio Fabrizi Selected Research

Neoplasms (Cancer)

1/2014

Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizio Fabrizi Research Topics

Disease

45	Infections 12/2022 - 05/2002
31	Chronic Renal Insufficiency 12/2022 - 10/2008
28	Hepatitis C 12/2023 - 07/2002
17	Liver Diseases (Liver Disease) 07/2021 - 09/2002
16	Chronic Kidney Failure (Chronic Renal Failure) 09/2019 - 08/2005
13	Glomerulonephritis 12/2023 - 01/2004
11	Hepatitis B 01/2014 - 03/2002
10	Chronic Hepatitis C 09/2021 - 10/2008
10	Proteinuria 01/2020 - 11/2008
9	Kidney Diseases (Kidney Disease) 12/2022 - 11/2008
9	Renal Insufficiency (Renal Failure) 01/2020 - 10/2008
7	Viremia 01/2020 - 05/2002
6	Hepatitis 04/2021 - 09/2002
6	Cryoglobulinemia 08/2015 - 07/2002
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2010
5	Fibrosis (Cirrhosis) 07/2021 - 01/2004
4	Diabetes Mellitus 07/2010 - 10/2005
3	Hematuria 01/2020 - 01/2013
3	Hemolytic Anemia 01/2020 - 05/2011
3	Ascites 01/2017 - 01/2013
2	Uremia 11/2020 - 01/2020
2	Virus Diseases (Viral Diseases) 06/2018 - 01/2013
2	Anemia 06/2018 - 05/2013
2	Sepsis (Septicemia) 08/2015 - 07/2010
2	Vasculitis (Vasculitides) 01/2014 - 05/2013
2	Chronic Hepatitis B 10/2011 - 06/2010
1	Azotemia 10/2022
1	COVID-19 05/2022
1	Posterior Leukoencephalopathy Syndrome 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2015
1	Nephritis 03/2014
1	Purpura 01/2014
1	Neoplasms (Cancer) 01/2014
1	HIV Infections (HIV Infection) 07/2013
1	Pneumonia (Pneumonitis) 05/2013
1	Necrosis 01/2013

Drug/Important Bio-Agent (IBA)

43	Antiviral Agents (Antivirals)IBA 12/2023 - 07/2003
27	InterferonsIBA 10/2021 - 03/2002
16	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 07/2002
8	SofosbuvirIBA 12/2023 - 01/2015
7	VaccinesIBA 03/2021 - 07/2006
7	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2002
6	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 11/2020 - 07/2006
6	Rituximab (Mabthera)FDA Link 08/2015 - 11/2008
6	Lamivudine (Epivir)FDA Link 09/2012 - 03/2002
5	CreatinineIBA 01/2020 - 04/2012
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2014 - 05/2002
4	elbasvirIBA 07/2021 - 01/2015
4	grazoprevirIBA 07/2021 - 01/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2013 - 11/2008
3	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020 - 01/2012
3	CryoglobulinsIBA 06/2018 - 07/2002
3	SimeprevirIBA 07/2016 - 01/2015
3	entecavir FDA Link 01/2014 - 06/2010
3	Cytotoxins (Cytolysins)IBA 04/2013 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 03/2004
2	Transaminases (Aminotransferases)IBA 04/2021 - 09/2002
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2020 - 01/2005
2	Protease Inhibitors (Protease Inhibitor)IBA 07/2016 - 05/2016
2	AntigensIBA 12/2015 - 01/2005
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015 - 01/2015
2	daclatasvirIBA 01/2015 - 01/2015
2	telaprevirIBA 01/2015 - 01/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015 - 11/2008
2	Hepatitis B e AntigensIBA 01/2014 - 03/2004
1	Ferritins (Ferritin)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	AntibodiesIBA 05/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 05/2022
1	EnzymesIBA 05/2022
1	Immunoglobulin G (IgG)IBA 05/2022
1	Immunoglobulin M (IgM)IBA 05/2022
1	Nucleocapsid ProteinsIBA 05/2022
1	glecaprevir and pibrentasvirIBA 07/2021
1	hepatitis B vaccine AS04IBA 11/2020
1	N 30IBA 07/2018
1	NucleotidesIBA 10/2017
1	SteroidsIBA 08/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2015
1	asunaprevirIBA 01/2015
1	paritaprevirIBA 01/2015
1	Ritonavir (Norvir)FDA Link 01/2015
1	ombitasvirIBA 01/2015
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 01/2015
1	dasabuvirIBA 01/2015
1	Phosphates (Orthophosphate)IBA 01/2014
1	TransferasesIBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Monoclonal AntibodiesIBA 04/2013

Therapy/Procedure

50	Therapeutics 12/2022 - 03/2002
21	Renal Dialysis (Hemodialysis) 12/2023 - 05/2002
17	Kidney Transplantation 12/2022 - 03/2002
12	Liver Transplantation 01/2022 - 08/2005
7	Transplantation 01/2020 - 09/2004
4	Plasma Exchange 08/2015 - 11/2008
2	Peritoneal Dialysis 01/2013 - 05/2002
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Blood Transfusion (Blood Transfusions) 06/2018
1	Organ Transplantation 05/2013